A disease of the present: Scurvy in “well-nourished” patients - 23/10/13
Doi : 10.1016/j.jaad.2013.04.051
Amir Al-Dabagh a, Brandy-Joe Milliron, PhD b, Lindsay Strowd, MD a, Steven R. Feldman, MD, PhD a, c, d, ⁎ 
a Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC
b Department of Social Science and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC
c Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC
d Department of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC
∗Correspondence to: Steven R. Feldman, MD, PhD, Department of Dermatology, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1071
| Funding sources: None. |
|
| Conflicts of interest: The Center for Dermatology Research is supported by an unrestricted educational grant from Galderma Laboratories, LP. Dr Feldman is a consultant and speaker for Galderma, Stiefel/GlaxoSmithKline, Abbott Labs, Warner Chilcott, Janssen, Amgen, Photomedex, Genentech, BiogenIdec, and Bristol Myers Squibb. Dr Feldman has received grants from Galderma, Astellas, Abbott Labs, Warner Chilcott, Janssen, Amgen, Photomedex, Genentech, BiogenIdec, Coria/Valeant, Pharmaderm, Ortho Pharmaceuticals, Aventis Pharmaceuticals, Roche Dermatology, 3M, Bristol Myers Squibb, Stiefel/GlaxoSmithKline, Novartis, Medicis, Leo, HanAll Pharmaceuticals, Celgene, Basilea, and Anacor, and has received stock options from Photomedex. Mr Al-Dabagh, Dr Milliron, and Dr Strowd have no conflicts to disclose. |
© 2013
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 69 - N° 5
P. e246-e247 - novembre 2013 Retour au numéro
Article précédent
- Multiple pigmented eccrine hidrocystomas within scars in a patient with recessive dystrophic epidermolysis bullosa
- Denise K. Woo, Tor Shwayder
- Cutaneous sarcoidal granuloma after botulinum toxin type A injection
- Till Assmann, Dieter Krahl, Renz Mang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?